Page 43 - Demo

1646-51, DOI: 10.1038/oby.2010.6.123. Nicol, G.E., et al., Metabolic Effects of Antipsychotics onAdiposity and Insulin Sensitivity in Youths: ARandomized Clinical Trial. JAMA Psychiatry, 2018.75(8):p.788-796,DOI:10.1001/jamapsychiatry.2018.1088.124. Taveira, T.H., et al., The effect of naltrexone on body fatmass in olanzapine-treated schizophrenic orschizoaffective patients: a randomized double-blindplacebo- controlled pilot study. J Psychopharmacol,2014. 28(4): p. 395-400, DOI:10.1177/0269881113509904.125. Kajimura, S., P. Seale, and B.M. Spiegelman,Transcriptional control of brown fat development. CellMetab, 2010. 11(4): p. 257-62, DOI:10.1016/j.cmet.2010.03.005.126. Kajimura, S., et al., Initiation of myoblast to brown fatswitch by a PRDM16-C/EBP- beta transcriptionalcomplex. Nature, 2009. 460(7259): p. 1154-8, DOI:10.1038/nature08262.127. van Marken Lichtenbelt, W.D., et al., Cold-activatedbrown adipose tissue in healthy men. N Engl J Med,2009. 360(15): p. 1500-8, DOI:10.1056/NEJMoa0808718.128. Orava, J., et al., Different metabolic responses of humanbrown adipose tissue to activation by cold and insulin.Cell Metab, 2011. 14(2): p. 272-9, DOI:10.1016/j.cmet.2011.06.012.129. Tseng, Y.H., et al., New role of bone morphogeneticprotein 7 in brown adipogenesis and energyexpenditure. Nature, 2008. 454(7207): p. 1000-4, DOI:10.1038/nature07221.130. Yang, X., S. Enerback, and U. Smith, Reduced expressionof FOXC2 and brown adipogenic genes in humansubjects with insulin resistance. Obes Res, 2003.11(10):p. 1182-91, DOI: 10.1038/oby.2003.163.131. Oh, J.E., et al., Inhibition of mouse brown adipocytedifferentiation by second- generation antipsychotics.Exp Mol Med, 2012. 44(9): p. 545-53, DOI:10.3858/emm.2012.44.9.062.132. Valverde, A.M. and M. Benito, The brown adipose cell: aunique model for understanding the molecularmechanism of insulin resistance. Mini Rev Med Chem,2005. 5(3): p. 269-78.133. Ota, M., et al., Resistance to excessive bodyweight gainin risperidone-injected rats. Clin Exp PharmacolPhysiol, 2005. 32(4): p. 279-87, DOI: 10.1111/j.1440-1681.2005.04184.x.134. Zhang, Q., et al., Olanzapine reduced brown adiposetissue thermogenesis and locomotor activity in femalerats. Prog Neuropsychopharmacol Biol Psychiatry,2014. 51: p. 172-80, DOI:10.1016/j.pnpbp.2014.02.003.135. Li, Y., et al., Secretin-Activated Brown Fat MediatesPrandial Thermogenesis to Induce Satiation. Cell,2018. 175(6): p. 1561-1574 e12, DOI:10.1016/j.cell.2018.10.016.136.Virtanen, K.A., et al., Functional brown adipose tissue inhealthy adults. N Engl J Med, 2009. 360(15): p. 1518-25, DOI: 10.1056/NEJMoa0808949.137. Robinson, L.J., et al., Brown adipose tissue activation asmeasured by infrared thermography by mildanticipatory psychological stress in lean healthyDOI: 10.1080/08039488.2016.1230649.110. Sapra, M., et al., Adiposity - independenthypoadiponectinemia as a potential marker of insulinresistance and inflammation in schizophrenia patientstreated with second generation antipsychotics.Schizophr Res, 2016. 174(1-3): p. 132-136, DOI:10.1016/j.schres.2016.04.051.111. Wampers, M., et al., Differential effects of olanzapineand risperidone on plasma adiponectin levels overtime: results from a 3-month prospective open-labelstudy. Eur Neuropsychopharmacol, 2012. 22(1): p. 17-26, DOI: 10.1016/j.euroneuro.2011.03.010.112. Richards, A.A., et al., Olanzapine treatment is associatedwith reduced high molecular weight adiponectin inserum: a potential mechanism for olanzapine- inducedinsulin resistance in patients with schizophrenia. JClin Psychopharmacol, 2006. 26(3): p. 232-7, DOI:10.1097/01.jcp.0000218404.64619.52.113. Cohn, T.A., et al., Insulin resistance and adiponectinlevels in drug-free patients with schizophrenia: Apreliminary report. Can J Psychiatry, 2006. 51(6): p.382-6, DOI: 10.1177/070674370605100608.114.van Nimwegen, L.J., et al., Hepatic insulin resistance inantipsychotic naive schizophrenic patients: stableisotope studies of glucose metabolism. J ClinEndocrinol Metab, 2008. 93(2): p. 572-7, DOI:10.1210/jc.2007-1167.115. Xu, A., et al., Testosterone selectively reduces the highmolecular weight form of adiponectin by inhibiting itssecretion from adipocytes. J Biol Chem, 2005.280(18):p. 18073-80, DOI: 10.1074/jbc.M414231200.116. O%u2019Connell, K., J. Thakore, and K.K. Dev, Levels of S100Bare raised in female patients with schizophrenia. BMCPsychiatry, 2013. 13: p. 146, DOI: 10.1186/1471- 244X13-146.117. Steiner, J., et al., S100B Serum Levels in SchizophreniaAre Presumably Related to Visceral Obesity and InsulinResistance. Cardiovasc Psychiatry Neurol, 2010.2010:p. 480707, DOI: 10.1155/2010/480707.118. Liu, Y., D.C. Buck, and K.A. Neve, Novel interaction ofthe dopamine D2 receptor and the Ca2+ bindingprotein S100B: role in D2 receptor function. MolPharmacol, 2008. 74(2): p. 371-8, DOI:10.1124/mol.108.044925.119. Hahn, M.K., et al., Acute effects of single-doseolanzapine on metabolic, endocrine, andinflammatory markers in healthy controls. J ClinPsychopharmacol, 2013. 33(6):p. 740-6, DOI:10.1097/JCP.0b013e31829e8333.120. Samra, J.S., et al., Effects of physiologicalhypercortisolemia on the regulation of lipolysis insubcutaneous adipose tissue. J Clin Endocrinol Metab,1998. 83(2): p. 626-31, DOI: 10.1210/jcem.83.2.4547.121. Vidarsdottir, S., et al., Orally disintegrating and oralstandard olanzapine tablets similarly elevate thehomeostasis model assessment of insulin resistanceindex and plasma triglyceride levels in 12 healthymen: a randomized crossover study. J Clin Psychiatry,2010. 71(9): p. 1205-11, DOI:10.4088/JCP.08m04654yel.122. Fountaine, R.J., et al., Increased food intake and energyexpenditure following administration of olanzapine tohealthy men. Obesity (Silver Spring), 2010. 18(8): p.42ANALESRANFwww.analesranf.comSecond-generation antipsychotic drugs and their impact onadipose tissuePatricia Rada, V%u00edtor Ferreira y %u00c1ngela M. ValverdeAn. R. Acad. Farm.Vol. 90. n%u00ba 1 (2024) %u00b7 pp. 21-44